Mr Karelis has extensive experience working with start-up companies in particular in the healthcare sector. He has been involved in the medicinal cannabis sector since 2014 and has been involved as a Founding Director/Shareholder of several of Australia’s leading medicinal cannabis companies including the ASX-listed companies AusCann Group Holdings Ltd (founding Director), Zelda Therapeutics Ltd (Chairman) and CannPal Animal Therapeutics Ltd (founding shareholder).
Mr Karelis graduated from the University of Western Australia with a Bachelor of Science (Hons) majoring in Biochemistry and Microbiology and a Master of Business Administration (MBA). He is also a Fellow of the Financial Services Institute of Australia, a Fellow of the Australian Institute of Company Directors and has qualified as a Chartered Financial Analyst (CFA) from the CFA Institute in the United States.